Results 121 to 130 of about 1,271 (136)

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2017
Jørgen Vestbo, Alberto A Papi, Massimo Corradi   +2 more
exaly  

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study

Lancet, The, 2020
Giuliano Rizzardini, Susan Swindells, Vasiliki Chounta   +2 more
exaly  

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients

Lancet, The, 1997
Hillel W Cohen
exaly  

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Lancet, The, 2019
Fabrice Carrat, Hélène Fontaine, Victor de Lédinghen   +2 more
exaly  

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

Lancet, The, 2019
Piotr Kuna, Pierluigi Paggiaro, Alberto A Papi   +2 more
exaly  

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Lancet, The, 2017
Juan J González-García, Joseph J Eron, Daniel Podzamczer   +2 more
exaly  

Regulation of gene expression by cis-acting long non-coding RNAs

Nature Reviews Genetics, 2019
Igor Ulitsky
exaly  

24-Karat or fool’s gold? Consequences of real team and co-acting group membership in healthcare organizations

European Journal of Work and Organizational Psychology, 2015
Joanne Lyubovnikova, Jeremy F Dawson
exaly  

Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Jesse K Mckenney, A Oliver Sartor, Mahul B Amin   +2 more
exaly  

Priorities for the primary prevention of breast cancer

Ca-A Cancer Journal for Clinicians, 2014
exaly